Subtopic Deep Dive
Fontan Procedure
Research Guide
What is Fontan Procedure?
The Fontan procedure is a palliative surgical technique establishing systemic venous return directly to the pulmonary arteries without a subpulmonary ventricle in patients with single ventricle congenital heart defects.
Developed in stages since the 1970s, it completes staged palliation after procedures like the Norwood or Glenn shunt. Studies focus on long-term outcomes including survival rates, thrombosis risk, and protein-losing enteropathy. Over 1000 papers cite key works like Khairy et al. (2007, 1002 citations) on Fontan mortality predictors.
Why It Matters
Fontan procedure enables survival into adulthood for single ventricle patients, but faces challenges like 10-20% late mortality from heart failure and arrhythmias (Khairy et al., 2007). Guidelines by Baumgartner et al. (2010, 2319 citations) and Baumgartner et al. (2020, 1979 citations) standardize management, improving patient selection and anticoagulation strategies. Risk adjustment via Jenkins et al. (2002, 1365 citations) RACHS-1 method aids surgical benchmarking, reducing in-hospital mortality comparisons across centers.
Key Research Challenges
Long-term Survival Predictors
Identifying mortality risks beyond 20 years post-Fontan remains critical, with arrhythmias and heart failure dominant (Khairy et al., 2007). Data from single-center registries limit generalizability. Multicenter studies needed for refined risk models.
Thrombosis Prevention Strategies
Thromboembolic events occur in 10-20% of patients due to sluggish pulmonary flow. Optimal anticoagulation regimens lack consensus despite guidelines (Baumgartner et al., 2020). Biomarker-based protocols require validation.
Protein-losing Enteropathy Management
PLE affects 5-15% of Fontan patients, causing hypoalbuminemia and edema. Pathophysiology links to elevated venous pressures, but treatments like octreotide show variable efficacy. Longitudinal studies essential for interventions.
Essential Papers
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)
Helmut Baumgartner, Philipp Bonhoeffer, N M S De Groot et al. · 2010 · European Heart Journal · 2.3K citations
Guidelines summarize and evaluate all currently available evidence ona \nparticular issuewith the aimof assisting physicians in selecting the best \nmanagement strategies for an individual ...
2020 ESC Guidelines for the management of adult congenital heart disease
Helmut Baumgartner, Julie De Backer, Sonya V. Babu‐Narayan et al. · 2020 · European Heart Journal · 2.0K citations
info:eu-repo/semantics/published
Congenital Heart Disease in the General Population
Ariane Marelli, Andrew S. Mackie, Raluca Ionescu‐Ittu et al. · 2007 · Circulation · 1.7K citations
Background— Empirical data on the changing epidemiology of congenital heart disease (CHD) are scant. We determined the prevalence, age distribution, and proportion of adults and children with sever...
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Karen Stout, Curt J. Daniels, Jamil Aboulhosn et al. · 2018 · Circulation · 1.5K citations
PREAMBLESince 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines (guidelines) with recommendat...
Consensus-based method for risk adjustment for surgery for congenital heart disease
Kathy J. Jenkins, Kimberlee Gauvreau, Jane W. Newburger et al. · 2002 · Journal of Thoracic and Cardiovascular Surgery · 1.4K citations
The RACHS-1 method should adjust for baseline risk differences and allow meaningful comparisons of in-hospital mortality for groups of children undergoing surgery for congenital heart disease.
Long-Term Survival, Modes of Death, and Predictors of Mortality in Patients With Fontan Surgery
Paul Khairy, Susan M. Fernandes, John E. Mayer et al. · 2007 · Circulation · 1.0K citations
Background— To better define determinants of mortality in patients with univentricular physiology, a database registry was created of patients born in 1985 or earlier with Fontan surgery who were f...
Comparison of Shunt Types in the Norwood Procedure for Single-Ventricle Lesions
Richard G. Ohye, Lynn A. Sleeper, Lynn Mahony et al. · 2010 · New England Journal of Medicine · 897 citations
In children undergoing the Norwood procedure, transplantation-free survival at 12 months was better with the RVPA shunt than with the MBT shunt. After 12 months, available data showed no significan...
Reading Guide
Foundational Papers
Start with Khairy et al. (2007) for survival and mortality modes in Fontan patients, then Jenkins et al. (2002) for RACHS-1 risk adjustment essentials, followed by Baumgartner et al. (2010) guidelines for management foundations.
Recent Advances
Study Baumgartner et al. (2020) for updated ESC adult CHD guidelines and Stout et al. (2018) AHA/ACC guidelines addressing contemporary Fontan care.
Core Methods
Core techniques include RACHS-1 scoring (Jenkins et al., 2002), Kaplan-Meier survival analysis (Khairy et al., 2007), and multivariable Cox regression for mortality predictors.
How PapersFlow Helps You Research Fontan Procedure
Discover & Search
Research Agent uses searchPapers with 'Fontan procedure long-term outcomes' to retrieve Khairy et al. (2007), then citationGraph reveals 1002 citing papers including Diller et al. (2015), and findSimilarPapers uncovers related single-ventricle studies.
Analyze & Verify
Analysis Agent applies readPaperContent to extract survival curves from Khairy et al. (2007), verifies claims with CoVe against Baumgartner et al. (2020) guidelines, and runs PythonAnalysis on RACHS-1 scores from Jenkins et al. (2002) for statistical mortality risk computation with GRADE evidence grading.
Synthesize & Write
Synthesis Agent detects gaps in thrombosis management across guidelines, flags contradictions between ESC and AHA recommendations, then Writing Agent uses latexEditText, latexSyncCitations for Khairy et al., and latexCompile to generate a review manuscript with exportMermaid flowcharts of Fontan circulation.
Use Cases
"Analyze survival data from Fontan cohorts using Python"
Research Agent → searchPapers 'Fontan survival Khairy' → Analysis Agent → readPaperContent + runPythonAnalysis (pandas survival curves, Kaplan-Meier stats from Khairy et al. 2007) → matplotlib plot of hazard ratios.
"Draft LaTeX review on Fontan guidelines evolution"
Synthesis Agent → gap detection Baumgartner 2010 vs 2020 → Writing Agent → latexEditText (insert comparisons) → latexSyncCitations (add 5 guidelines) → latexCompile → PDF with synchronized bibliography.
"Find code for Fontan risk modeling from papers"
Research Agent → searchPapers 'Fontan RACHS-1 model' → paperExtractUrls (Jenkins 2002 supplements) → paperFindGithubRepo → githubRepoInspect → R script for risk adjustment exported via exportCsv.
Automated Workflows
Deep Research workflow scans 50+ Fontan papers via searchPapers → citationGraph → structured report with GRADE-graded survival predictors from Khairy et al. (2007). DeepScan applies 7-step CoVe to verify thrombosis rates across Baumgartner guidelines. Theorizer generates hypotheses on PLE mechanisms from Ohye et al. (2010) Norwood data linkages.
Frequently Asked Questions
What defines the Fontan procedure?
Fontan procedure redirects inferior vena cava flow to pulmonary arteries, completing palliation for single ventricle hearts after bidirectional Glenn shunt.
What are main methods in Fontan research?
Longitudinal cohort studies (Khairy et al., 2007), risk adjustment scoring (RACHS-1, Jenkins et al., 2002), and guideline consensus (Baumgartner et al., 2020) evaluate outcomes.
What are key papers on Fontan outcomes?
Khairy et al. (2007, Circulation, 1002 citations) reports 20-year survival and predictors; Baumgartner et al. (2010, 2319 citations) provides ESC management guidelines.
What open problems exist in Fontan studies?
Optimal anticoagulation for thrombosis prevention, PLE pathophysiology interventions, and personalized risk stratification beyond RACHS-1 lack prospective trials.
Research Congenital Heart Disease Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Fontan Procedure with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Congenital Heart Disease Studies Research Guide